SNWV
SANUWAVE Health, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$5.85
−1.35%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$6.05
From 52W high−83.45%
Volume24896.00
Market cap$50.32M
P/E (TTM)3.5x
P/S (TTM)1.1x
Div yield—
Key dataNov 4, 2026
Open
$6.05
From 52W high
−83.45%
Volume
24896.00
Market cap
$50.32M
ValuationView details →
P/E (Fwd)
4.6x
EV/EBITDA
3.1x
P/E (TTM)
3.5x
RSI (14)
64.9
MomentumView details →
1D Return
−1.35%
YTD Return
−79.89%
SummaryUpdated Jun 1, 2026
SANUWAVE Health, Inc. (NASDAQ:SNWV) is a medical device company founded in 2005 and headquartered in Suwanee, Georgia. The company specializes in developing and commercializing shock wave technology for regenerative medicine applications. SANUWAVE went public in 2009 and recently uplisted to NASDAQ in March 2025 after trading on lower exchanges. The company has transformed from a research-focused organization into a commercial-stage medical device manufacturer, experiencing significant revenue growth and expanding its market presence in wound care and other therapeutic applications.
Similar companies
Latest newsMore news →
Sanuwave Health, Inc. and SANUWAVE Health, Inc. amended their credit agreement with the lenders and JPMorgan Chase Bank, N.A., Toronto Branch, waiving a specified fixed-charge-coverage-ratio default and changing lender-consent requirements and permitted thresholds.7d agoSANUWAVE Health, Inc. received a Nasdaq notice dated September 23, 2026 that it no longer complies with the $35 million minimum market value of listed securities requirement under Nasdaq Listing Rule 5450(b)(2)(A), giving it until March 22, 2027 to regain compliance.40d ago